IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,826 | +319.6% | 282 | +107.4% | 0.00% | – |
| Q2 2023 | $2,580 | +22.3% | 136 | 0.0% | 0.00% | – |
| Q1 2023 | $2,109 | -7.2% | 136 | +6.2% | 0.00% | – |
| Q4 2022 | $2,272 | -67.5% | 128 | -84.8% | 0.00% | – |
| Q4 2021 | $7,000 | -56.2% | 840 | -53.3% | 0.00% | -100.0% |
| Q3 2021 | $16,000 | 0.0% | 1,800 | +20.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | -33.3% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $24,000 | -65.2% | 1,500 | 0.0% | 0.00% | -66.7% |
| Q4 2020 | $69,000 | -43.9% | 1,500 | -57.1% | 0.00% | -57.1% |
| Q3 2020 | $123,000 | +0.8% | 3,500 | -30.0% | 0.01% | 0.0% |
| Q2 2020 | $122,000 | +125.9% | 5,000 | +42.9% | 0.01% | +40.0% |
| Q1 2020 | $54,000 | – | 3,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |